Jegerlehner A - Search Results

1

Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.

Schmitz N, Beerli RR, Bauer M, Jegerlehner A, Dietmeier K, Maudrich M, Pumpens P, Saudan P, Bachmann MF. Schmitz N, et al. Among authors: jegerlehner a. Eur J Immunol. 2012 Apr;42(4):863-9. doi: 10.1002/eji.201041225. Eur J Immunol. 2012. PMID: 22531913 Free article.

2

Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors.

Hinton HJ, Jegerlehner A, Bachmann MF. Hinton HJ, et al. Among authors: jegerlehner a. Curr Top Microbiol Immunol. 2008;319:1-15. doi: 10.1007/978-3-540-73900-5_1. Curr Top Microbiol Immunol. 2008. PMID: 18080412 Review.

3

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Jegerlehner A, et al. J Immunol. 2004 May 1;172(9):5598-605. doi: 10.4049/jimmunol.172.9.5598. J Immunol. 2004. PMID: 15100303

4

TLR9 signaling in B cells determines class switch recombination to IgG2a.

Jegerlehner A, Maurer P, Bessa J, Hinton HJ, Kopf M, Bachmann MF. Jegerlehner A, et al. J Immunol. 2007 Feb 15;178(4):2415-20. doi: 10.4049/jimmunol.178.4.2415. J Immunol. 2007. PMID: 17277148

5

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.

Bessa J, Schmitz N, Hinton HJ, Schwarz K, Jegerlehner A, Bachmann MF. Bessa J, et al. Among authors: jegerlehner a. Eur J Immunol. 2008 Jan;38(1):114-26. doi: 10.1002/eji.200636959. Eur J Immunol. 2008. PMID: 18081037 Free article.

6

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses.

Bessa J, Jegerlehner A, Hinton HJ, Pumpens P, Saudan P, Schneider P, Bachmann MF. Bessa J, et al. Among authors: jegerlehner a. J Immunol. 2009 Sep 15;183(6):3788-99. doi: 10.4049/jimmunol.0804004. Epub 2009 Aug 26. J Immunol. 2009. PMID: 19710454 Free article.

7

Bacterially produced recombinant influenza vaccines based on virus-like particles.

Jegerlehner A, Zabel F, Langer A, Dietmeier K, Jennings GT, Saudan P, Bachmann MF. Jegerlehner A, et al. PLoS One. 2013 Nov 18;8(11):e78947. doi: 10.1371/journal.pone.0078947. eCollection 2013. PLoS One. 2013. PMID: 24260136 Free PMC article.

8

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation.

Jegerlehner A, Storni T, Lipowsky G, Schmid M, Pumpens P, Bachmann MF. Jegerlehner A, et al. Eur J Immunol. 2002 Nov;32(11):3305-14. doi: 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J. Eur J Immunol. 2002. PMID: 12555676 Free article.

9

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.

Storni T, Lechner F, Erdmann I, Bächi T, Jegerlehner A, Dumrese T, Kündig TM, Ruedl C, Bachmann MF. Storni T, et al. Among authors: jegerlehner a. J Immunol. 2002 Mar 15;168(6):2880-6. doi: 10.4049/jimmunol.168.6.2880. J Immunol. 2002. PMID: 11884458

10

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.

Ruedl C, Schwarz K, Jegerlehner A, Storni T, Manolova V, Bachmann MF. Ruedl C, et al. Among authors: jegerlehner a. J Virol. 2005 Jan;79(2):717-24. doi: 10.1128/JVI.79.2.717-724.2005. J Virol. 2005. PMID: 15613299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters